← Back to home

INFILTRATING BLADDER UROTHELIAL CARCINOMA WITH GLANDULAR DIFFERENTIATION

Clinical trials for INFILTRATING BLADDER UROTHELIAL CARCINOMA WITH GLANDULAR DIFFERENTIATION explained in plain language.

Never miss a new study

Get alerted when new INFILTRATING BLADDER UROTHELIAL CARCINOMA WITH GLANDULAR DIFFERENTIATION trials appear

Sign up with your email to follow new studies for INFILTRATING BLADDER UROTHELIAL CARCINOMA WITH GLANDULAR DIFFERENTIATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug duo targets Tough-to-Treat bladder cancer

Disease control Ongoing

This study is testing whether a combination of two drugs, pemetrexed and avelumab, can help control advanced bladder cancer that has spread and has a specific genetic feature (MTAP-deficient). The trial is for people whose cancer has worsened after prior treatment. Researchers wa…

Matched conditions: INFILTRATING BLADDER UROTHELIAL CARCINOMA WITH GLANDULAR DIFFERENTIATION

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

INFILTRATING BLADDER UROTHELIAL CARCINOMA WITH GLANDULAR DIFFERENTIATION

Get alerted when new INFILTRATING BLADDER UROTHELIAL CARCINOMA WITH GLANDULAR DIFFERENTIATION trials appear

New drug duo targets Tough-to-Treat bladder cancer